EMA's Final Call On Alzheimer's Drug Leqembi Imminent

 
• By Neena Brizmohun
  
Hands Holding Brain With Puzzle Paper Cutout Memory Loss,
The EU marketing application for the Alzheimer's drug, Leqembi, is back in the spotlight (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet